What Is the Clinical Effectiveness, Cost Effectiveness and Implications for Safety of Assessing Anti-Tumour Necrosis Factor (TNF)a Drug Levels and Antibodies in Children With Moderate to Severe Inflammatory Bowel Disease (IBD) Compared With Existing Clinical Strategies in Use in NHSScotland? In Response to an Enquiry from NHS Greater Glasgow and Clyde - Technologies Scoping Report

• $28.71

• $24.32

Save $2.97

• RRP $24.60
• $21.63

• $14.62

• $17.45

• $15.03

• $23.49

• $20.67

• $27.34

• $20.66

Save $0.21

• RRP $20.49
• $20.28

• $21.56

Save $10.04

• RRP $34.18
• $24.14

Save $3.53

• RRP $23.23
• $19.70

Save $0.71

• RRP $13.66
• $12.95

• $15.12

• $53.32

• $14.42

• $14.78

Save $5.43

• RRP $30.08
• $24.65

Save $0.30

• RRP $13.66
• $13.36

Save $1.49

• RRP $27.34
• $25.85

• $17.76